Search

Engineering of the Lrp/AsnC-type transcriptional regulator DecR as a genetically encoded biosensor for multilevel optimization of L-cysteine biosynthesis pathway in Escherichia coli

메타 데이터

바이오화학분류
    • 바이오플라스틱
      1. 기타
    • 바이오정밀화학
      1. 기타
    • 화장품용 기능성소재
      1. 기타
    • 의료용 화학소재
      1. 식품첨가제
논문

Engineering of the Lrp/AsnC-type transcriptional regulator DecR as a genetically encoded biosensor for multilevel optimization of L-cysteine biosynthesis pathway in Escherichia coli

학술지

Biotechnology and bioengineering

저자명

Zhou, Zhiyou; Li, Zonglin; Zhong, Yahui; Xu, Shuai; Li, Zhimin

초록

<P><B>Abstract</B><P>L&#x2010;cysteine is an important sulfur&#x2010;containing amino acid being difficult to produce by microbial fermentation. Due to the lack of high&#x2010;throughput screening methods, existing genetically engineered bacteria have been developed by simply optimizing the expression of L&#x2010;cysteine&#x2010;related genes one by one. To overcome this limitation, in this study, a biosensor&#x2010;based approach for multilevel biosynthetic pathway optimization of L&#x2010;cysteine from the DecR regulator variant of <I>Escherichia coli</I> was applied. Through protein engineering, we obtained the DecR<SUP>N29Y/C81E/M90Q/M99E</SUP> variant&#x2010;based biosensor with improved specificity and an 8.71&#x2010;fold increase in dynamic range. Using the developed biosensor, we performed high&#x2010;throughput screening of the constructed promoter and RBS combination library, and successfully obtained the optimized strain, which resulted in a 6.29&#x2010;fold increase in L&#x2010;cysteine production. Molecular dynamics (MD) simulations and electrophoretic mobility shift analysis (EMSA) showed that the N29Y/C81E/M90Q/M99E variant had enhanced induction activity. This enhancement may be due to the increased binding of the variant to DNA in the presence of L&#x2010;cysteine, which enhances transcriptional activation. Overall, our biosensor&#x2010;based strategy provides a promising approach for optimizing biosynthetic pathways at multiple levels. The successful implementation of this strategy demonstrates its potential for screening improved recombinant strains.</P></P>

발행연도

2024

발행기관

Wiley (John WileySons)

ISSN

0006-3592

ISSN

1097-0290

121

7

페이지

pp.2133-2146

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2024-07-01

Export

About

Search

Trend